Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Levonadifloxacin - Wockhardt

Drug Profile

Levonadifloxacin - Wockhardt

Alternative Names: S-nadifloxacin; WCK 771; WCK 771A

Latest Information Update: 29 May 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Wockhardt
  • Class Anti-infectives; Antibacterials; Fluoroquinolones; Quinolizines; Small molecules
  • Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase IV inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Skin and soft tissue infections
  • No development reported Methicillin-resistant Staphylococcus aureus infections

Most Recent Events

  • 13 Apr 2019 Pharmacodynamics data from preclinical studies in Methicillin-resistant Staphylococcus aureus infections presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID -2019)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Methicillin-resistant-Staphylococcus-aureus-infections(In volunteers) in USA (IV, Infusion)
  • 30 Jun 2017 Phase-III clinical trials in Skin and soft tissue infections in India (IV) (CTRI/2017/06/008843)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top